Published in Drug Law Weekly, November 18th, 2008
Fiscal Fourth Quarter Highlights
-- Total revenue of $17.2 billion, up 5 percent.
-- Diluted earnings per share from continuing operations of $0.73, up 18 percent.
-- Pharmaceutical Distribution operating margin of 1.19 percent, up 17 basis points.
-- Cash flow from operations of $514...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.